ProCE Banner Activity

How Cultural Competency Can Advance High-Quality Care for IBD Patients of South Asian Background (in Hindi)

Clinical Thought

Two South Asian patients with IBD and a gastroenterologist practicing in India reflect on how cultural competency can advance high-quality care for IBD patients of SA background.

Released: September 27, 2023

Share

Faculty

Tina Aswani-Omprakash

Tina Aswani-Omprakash, MPH

President and Co-Founder, South Asian IBD Alliance
Mount Sinai Department of Medicine
Dr. Henry D. Janowitz Division of Gastroenterology
New York, New York

Mahalakshmi Parakala

Mahalakshmi Parakala

Patient advocate

Kiran Peddi

Kiran Peddi, MRCP (UK), FRCP (Lon), CCT Gastro (UK)

Consultant Gastroenterologist
Yashoda Hospitals
Hyderabad, India

Provided by

Provided by Clinical Care Options, LLC in partnership with the South Asian IBD Alliance.

ProCE Banner
ProCE Banner

Supporters

This activity is supported by independent educational grants from Takeda Pharmaceuticals U.S.A., Inc., Janssen Pharmaceutical Companies, Lilly, Bristol Myers Squibb (BMS), and Hollister, Inc.

Bristol Myers Squibb

Hollister, Inc.

Janssen Pharmaceutical Companies

Lilly

Takeda Pharmaceuticals U.S.A., Inc.

Faculty Disclosure

Primary Author

Tina Aswani-Omprakash, MPH

President and Co-Founder, South Asian IBD Alliance
Mount Sinai Department of Medicine
Dr. Henry D. Janowitz Division of Gastroenterology
New York, New York

Tina Aswani-Omprakash, MPH: consultant/advisor/speaker: AbbVie, Boehringer Ingelheim, Iterative Health Genentech/Roche, Hollister, Janssen, Pfizer, Takeda, Tillots.

Mahalakshmi Parakala,

Patient advocate

Mahalakshmi Parakala: independent contractor: Applied Molecular Transport.

Kiran Peddi, MRCP (UK), FRCP (Lon), CCT Gastro (UK)

Consultant Gastroenterologist
Yashoda Hospitals
Hyderabad, India

Kiran Peddi, MRCP (UK), FRCP (Lon) CCT (Gastro UK): consultant/advisor/speaker: Janssen, Takeda.